Vischer with TargImmune Therapeutics on CHF 17.7 m financing round

Vischer has acted as legal counsel to TargImmune Therapeutics, a private Swiss-based biotechnology firm, on the closing of its 2021 financing round, raising CHF 17.7 million.

The Vischer legal team was led by Matthias Staehelin (pictured) with Francesca Pesenti and Nicolai Bleskie (all corporate/m&a).

TargImmune Therapeutics focuses on drug development using novel targeted immunotherapies. The principal technology is the CTPIC technology platform that utilizes a proprietary non-viral vector to target and destroy cancer cells that overexpress certain receptors.

FabioAdmin

SHARE